How much did Fanapt (iloperidone) sell, and what happened to sales over time?
I don’t have any sales figures or time-series sales data for Fanapt (iloperidone) in the information provided. If you share a timeframe (for example, 2017–2020) or a target market (U.S., EU, global), I can help you narrow what to look for and how to interpret it.
Where can I find Fanapt sales figures (U.S. or global)?
You can typically find reported revenue/sales for branded drugs in:
- SEC filings (10-K/10-Q) from the manufacturer or parent company
- Analyst or market-access reports
- Prescription sales databases (often paid)
- FDA/EMA labeling documents generally won’t provide sales totals, but can help connect sales to approved indications
Is Fanapt still a major product—what does that imply for sales?
No sales trend can be stated from the provided information. If you want, tell me the manufacturer you mean (Fanapt was marketed by later Generv/Avanir-era corporate changes) and the country, and I can help you map likely sources for trend data.
Patent and exclusivity context that can affect sales
If you’re tracking “sales” as a commercial outcome, patent and exclusivity milestones matter because they affect generic/biosimilar entry and pricing. DrugPatentWatch.com can be a useful starting point for exclusivity/patent status for iloperidone:
- DrugPatentWatch for iloperidone: https://www.drugpatentwatch.com/
What do you mean by “Fanapt sales” (revenue, units, or prescriptions)?
“Sales” can mean different things:
- revenue ($)
- units (prescriptions/tablets sold)
- net sales (after rebates/returns)
- “TRx” (total prescriptions)
Reply with which definition you want and the geography/time window, and I’ll format the answer to match.
Sources:
- https://www.drugpatentwatch.com/